Skip to Main Content
1-877-YALEMDS
SpecialistsFact SheetsDepartmentsClinical TrialsNewsPatient ToolsFor Medical Professionals
1-877-YALEMDS
  • Search
  • Clinical Trials
  • Hari Deshpande

Clinical Trials

    • Cancer(4)
  • Head and Neck Cancers

    A Phase II Randomized Trial of Adjuvant Therapy With Pembrolizumab After Resection of Recurrent/Second Primary Head and Neck Squamous Cell Carcinoma With High Risk Features

    • Sarcoma Cancers, Kidney Cancer, Pediatric Cancers

      Phase 3 Accelerated BEP: A Randomised Phase 3 Trial of Accelerated Versus Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumors

      • Head and Neck Cancers

        Phase II Randomized Trial of Adjuvant Radiotherapy With or Without Cisplatin for p53 Mutated, Surgically Resected Squamous Cell Carcinoma of the Head and Neck (SCCHN)

        • Head and Neck Cancers

          Radiation Therapy With Cisplatin, Docetaxel, or Cetuximab After Surgery in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer

          • Ages18 years and older
          • GenderBoth
        • About Us
        • Contact Us
        • Donate
        • Referring Doctors
        • Clinical Keywords

        333 Cedar St.

        New Haven, CT 06510

        • Yale School of Medicine
        • Yale University
        • Terms & Privacy Policies
        • Accessibility at YSM
        • Patient Rights
        • HIPAA at Yale
        • Non-discrimination Statement
        Copyright 2025 Yale Medicine